Company Name: dynaCERT Inc. ISIN: CA26780A1084   Reason for the research: Research Comment Recommendation: Buy Target price: 0.75 CAD Target price on sight of: 31.12.2025 Last rating change: Analyst: Matthias Greiffenberger, Marcel Goldmann FY2024 revenues came in at CAD 1.60 million, significantly below our initial forecast of [ … ]

Company Name: bet-at-home.com AG ISIN: DE000A0DNAY5   Reason for the research: Update Recommendation: BUY from: 17.04.2025 Target price: EUR 5.50 Target price on sight of: 12 months Last rating change: Analyst: Frederik Jarchow Solid FY24 figures // Waiting for the ECJ decision; chgTopic: bet-at-home reported final FY24 figures  [ … ]

Company Name: Flughafen Wien AG ISIN: AT00000VIE62   Reason for the research: Update Recommendation: HOLD from: 17.04.2025 Target price: EUR 60.00 Target price on sight of: 12 months Last rating change: Analyst: Henry Wendisch Sound Q1 traffic results in the books Yesterday, FWAG released Mar’25 traffic figures marked by m [ … ]

Beiersdorf reported better-than-expected organic (org.) sales growth of 3.6% yoy in Q1 2025, a 1.0 ppt consensus (cons.) beat. Consumer, its largest segment, came in largely in line with cons. (org. +2.3% yoy), while Tesa exceeded market expectations (+10.7% vs cons. +4.0%), supported by positive momentum in the electronics business. The Consumer segment’s org. growth was supported by solid double-digit growth in Derma (+11.4%) and Healthcare sales (+10.8%), while its core brand NIVEA reported a moderate growth of 2.5%, amidst headwinds from strategic repositioning in China and a higher comparable base. Its premium line-up La Prairie dipped 17.5% from planned destocking and challenging market conditions in China. Despite the challenges, its FY 25 guidance remains intact. Beiersdorf continues to be an attractive player in the global skin care market, given its commitment to deliver innovation, with the recent Epicelline and Eucerin launches and the planned Thiamidol-based product launches in China. As these positives have already been priced in, and without any new price catalysts, the analysts maintain PT unchanged at EUR 146.00 and reiterate their BUY rating. The full update can be downloaded under https://www.research-hub.de/companies/Beiersdorf%20AG

METRO AG delists from the Frankfurt Stock Exchange and SDAX today, 16 April 2025, following EP Global Commerce’s (EPGC) public tender offer at EUR 5.33 per share. While the offer includes a premium, it falls short of reflecting METRO’s long-term potential under its sCore strategy. Management’s neutral stance on the offer, despite supporting the delisting, sends a conflicted signal. Claimed benefits like strategic focus and reduced regulation remain hard to quantify and primarily serve controlling shareholders. The loss of public oversight introduces long-term governance risks. With EPGC now firmly in control and little recourse for minority investors, this marks an opaque new chapter for METRO. SELL. The full update can be downloaded under https://www.research-hub.de/companies/research/Metro%20AG

MHP Hotel AG reported strong Q1 2025 KPIs with all indicators reaching record levels for the first quarter, including a 2 percentage point increase in occupancy to 67%, an 8% increase in ADR to EUR 203 and a 12% increase in RevPAR to EUR 137, boosted by the high yielding Koenigshof Munich opening in mid-2024. Revenue grew by 17% year-on-year to EUR 33.3m. Despite a challenging German hotel market, MHP is able to effectively manage costs and maintain pricing power in the premium and luxury segments. With an already promising development pipeline, including the Conrad Hamburg (summer 2025) and the Autograph Collection Stuttgart (2028), the company sees further potential from market consolidation in Europe. MHP reaffirms its 2025 guidance of EUR 180m in revenues and EUR 15m in EBITDA, assuming stable macroeconomic conditions. With mwb research’s analyst estimates unchanged, the analysts reiterate their BUY rating with a PT of EUR 3.30. The EV/EBITDA multiple of 2.6x in 25E leaves a large risk buffer should economic conditions deteriorate. The full update can be downloaded under https://research-hub.de/companies/MHP%20Hotel%20AG

Veganz Group AG has transformed from a vegan retailer into a food technology company, focusing on in-house production and distribution of innovative plant-based products, including Mililk (dairy alternatives), Peas on Earth (meat substitutes), and Happy Cheeze (plant-based cheese). Leveraging proprietary technology such as 2D food printing, the company enhances efficiency and sustainability while distributing through retail, food service, and online channels. In a highly competitive market, Veganz differentiates itself as a multi-category provider with a strong brand, innovative products, eco-friendly packaging, and cost-efficient logistics. While recent years have seen revenue declines and losses due to the business model pivot, the company is now at an inflection point, with strong growth prospects in plant-based milk and meat alternatives, which dominate the European market. With a strengthened balance sheet following a capital increase and bond restructuring, Veganz presents significant upside potential for long-term investors willing to accept above average risk. Coverage is initiated with a Spec. BUY rating and a EUR 11.00 price target, not including additional upside from vertical farming. The full update can be downloaded under https://research-hub.de/companies/veganz-group-ag

While short-term softness persists due to industry overcapacity and cyclical capex pauses, AIXTRON reasserted its long-term growth story at the German Select Conference, spotlighting structural tailwinds in SiC and GaN power markets. SiC demand is expected to rebound by 2026 with the accelerating shift to 800V EV platforms and GaN is on track to triple by decade’s end, fueled by energy efficiency and AI adoption. Meanwhile, with U.S. exposure below 10%, direct tariff risk remains limited, though the company acknowledges potential indirect headwinds should escalating trade tensions weigh on global macro conditions. The company is strategically rebuilding its cash buffer to EUR 200m to weather ongoing volatility. Q1 performance underpins confidence in FY25 guidance, and management remains focused on multiyear megatrends. In mwb research’s view, the recent share price pullback offers investors an opportunity to enter a potential long-term compounder at a cyclical trough. The analysts reiterate their BUY rating and price target of EUR 19.50. Please watch the full Roundtable here: https://researchhub.de/events/video/2025-04-08-12-00/AIXA-GR The full update can be downloaded under https://www.research-hub.de/companies/AIXTRON%20SE

Cicor reported solid Q1 2025 results, with sales up 22.2% yoy to CHF 131.1m, largely driven by recent acquisitions. Organic sales declined due to a one-off in Q1/24, while order intake grew 29.1% yoy. FY25 guidance was reaffirmed. Cicor also announced a strategic partnership with Mercury Mission Systems, including the takeover of a Swiss production site and a five-year high-value supply commitment. The collaboration could unlock further revenue upside. Combined with the pending MADES and Eolane acquisitions, Cicor continues to strengthen its position in aerospace and defense. Given recent strong share price performance, mwb research’s analysts move from BUY to HOLD, keeping their CHF 100.00 price target unchanged. The full update can be downloaded under https://www.research-hub.de/companies/Cicor%20Technologies%20Ltd

Company Name: LAIQON AG ISIN: DE000A12UP29   Reason for the research: Update Recommendation: BUY from: 15.04.2025 Target price: EUR 7.40 Target price on sight of: 12 months Last rating change: Analyst: Henry Wendisch FY'24 review: improved cost mix ahead of AuM scalingTo recap: Following preliminary sales and EBITDA figures of M [ … ]